Regeneron Pharmaceuticals earnings release, October 6, 2026

Regeneron Pharmaceuticals, Inc. (REGN) · Form 8-K, Item 2.02 · Filed · SEC filing

No press release attached to this 8-K.

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Regeneron Pharmaceuticals earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.